Patent ID: 8263592

Claim:
Compound of formula (I) including any stereochemically isomeric form thereof, wherein -A-B— represents wherein n is an integer 0 or 1; R 13 represents hydroxy or halo; R 14 represents hydrogen or C 1-6 alkyl; in the bivalent radicals (a-4), (a-5) and (a-6) any of the hydrogen atoms on the same or a different carbon atom may be replaced by halo; R 1 and R 2 are each independently selected from hydrogen, halo or C 1-6 alkyl; R 3 , R 4 , R 5 and R 6 are each independently selected from hydrogen, halo, C 1-6 alkyl, polyhaloC 1-6 alkyl, C 3-6 cycloalkyl, NO 2 , Cycle 1 , Cycle 2 , or X—R 8 wherein X represents O or NR 9 , wherein R 9 is hydrogen, C 1-6 alkyl or C 1-6 alkyloxyC 1-6 alkyl, and wherein R 8 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, polyhaloC 1-6 alkyl, C 1-6 alkyloxycarbonyl, C 1-6 alkylcarbonyl, polyhaloC 1-6 alkylcarbonyl, Cycle 2 , —(C═O)—(CH 2 ) m -Cycle 2 , —(C═O)—(CH 2 ) m —CH 2 —OH, —(C═O)—(CH 2 ) m —CH 2 —O—C 1-4 alkyl, or C 1-6 alkyl substituted with halo, hydroxy, cyano, C 3-6 cycloalkyl, C 1-6 alkyloxy, aminocarbonyl, phenyl, Cycle 1 , or Cycle 2 , or NR 11 R 12 wherein R 11 and R 12 are each independently selected from hydrogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, or C 1-6 alkyloxycarbonyl; m is an integer 0, 1 or 2; Cycle 1 is selected from wherein R 10 is hydrogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, or C 1-6 alkyloxycarbonyl; and Cycle 2 is selected from wherein R 10 is hydrogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkyloxycarbonyl or C 1-6 alkyloxycarbonyl substituted with halo or hydroxy; or a pharmaceutically acceptable acid addition salt thereof, or an N-oxide form thereof.